TB and opportunistic infections in tofacitinib-treated patients with rheumatoid arthritis
Winthrop KL, Park SH, Gul A et al. Ann Rheum Dis doi:10.1136/ annrheumdis-2015-207319 Read the paper here: ...
Annals of the Rheumatic Diseases
Meet the new Editor in Chief of ARD, Josef Smolen
The most successful journal in the field of rheumatology, the present and the future. Professor Josef Smolen (University of Vienna, Austria) introduces his ideas ...
Annals of the Rheumatic Diseases
ASP015K in patients with rheumatoid arthritis and an inadequate response to conventional DMARDs
To cite: Tanaka Y, Takeuchi T, Tanaka S, et al. Annals of the Rheumatic Diseases 2019. Published Online First: 26 July 2019. Read the full article here: ...
Annals of the Rheumatic Diseases
Evaluating drug-free remission with abatacept in early rheumatoid arthritis
Read the full paper (open access): http://goo.gl/FyEoKQ Rheumatoid arthritis (RA) is a progressive disease characterised by chronic joint inflammation and ...
Annals of the Rheumatic Diseases
Video clip assessment of a salivary gland ultrasound scoring system in Sjögren’s syndrome
To cite: Jousse-Joulin S, D'Agostino MA, Nicolas C, et al. Annals of the Rheumatic Diseases 2019. Read the full article here: ...
Annals of the Rheumatic Diseases
Efficacy and safety of peficitinib with rheumatoid arthritis and inadequate response to methotrexate
To cite: Takeuchi T, Tanaka Y, Tanaka S, et al. Annals of the Rheumatic Diseases 2019. Published Online First: 26 July 2019. Read the full article here: ...
Annals of the Rheumatic Diseases
Long-term safety and efficacy of sarilumab plus methotrexate
To cite: Genovese MC, van der Heijde D, Lin Y, et al. RMD Open 2019;5:e000887. Read the full article here: http://dx.doi.org/10.1136/rmdopen-2018-000887.
Annals of the Rheumatic Diseases
Diagnostic Utility of Serum IgG4 Concentrations in IgG4-related Disease
This EJournal Club series will engage rheumatologists, and other interested clinicians in an examination, discussion, and assessment of the most recent ...
ClevelandClinicCME
Baricitinib versus placebo or adalimumab on patient-reported outcomes in rheumatoid arthritis
To cite: Keystone EC, Taylor PC, Tanaka Y, et al. Annals of the Rheumatic Diseases 2017;76:1853-1861. Read the full article here: ...
Annals of the Rheumatic Diseases
Ixekizumab for the treatment of biologic-naive patients with active psoriatic arthritis
Annals of the Rheumatic Diseases
Outcomes in an RCT study of baricinitab in patients with rheumatoid arthritis
Read the full paper here: http://ard.bmj.com/content/76/4/694 To cite: Smolen JS, Kremer JM, Gaich CL, et al Patient-reported outcomes from a randomised ...
Annals of the Rheumatic Diseases
Maintenance of Clinical Remission in Early Axial Spondyloarthritis
To cite: Landewé RBM, van der Heijde D, Dougados M, et al. Annals of the Rheumatic Diseases 2019. Published Online First: 2020. Read the full article here: ...
Annals of the Rheumatic Diseases
Effects of tofacitinib with or without MTX on MRI endpoints in patients with early active RA
Annals of the Rheumatic Diseases
Researcher comment: COVID-19 risk factors in RMD patients | Pedro Machado
Pedro Machado discusses data from the COVID-19 Global Rheumatology Alliance registry on the risk factors for COVID-19 hospitalization in patients with ...
Medicine Matters rheumatology
IFI44L promoter methylation as a blood biomarker for systemic lupus erythematosus
Read the full paper here: Zhao M, Zhou Y, Zhu B, et al. Ann Rheum Dis;doi:10.1136/ annrheumdis-2015-208410 Objective Systemic lupus erythematosus is a ...
Annals of the Rheumatic Diseases
Impact of baseline anti-CCP2 concentration on outcomes following abatacept or adalimumab treatment
Read the paper here: http://ard.bmj.com/content/early/2015/09/10/annrheumdis-2015-207942.abstract doi:10.1136/annrheumdis-2015-207942 Objectives To ...
Annals of the Rheumatic Diseases
Baricitinib in patients with inadequate response or intolerance to conventional synthetic DMARDs
Annals of the Rheumatic Diseases
Anti-Drug Antibodies, Random Drug Levels with Efficacy in Certolizumab Pegol
This EJournal Club series will exam, discuss, and assess of the most recent peer-reviewed literature on rheumatic diseases. Dr. Leonard Calabrese will lead an ...
ClevelandClinicCME
EULAR School of Rheumatology: EULAR Intensive Assessment Seminar
Hear from one of the participants of EULAR's 1st Intensive Assessment Seminar 2016 for authors and convenors after having also taken the EULAR full 2-year ...
EULAR - European League against Rheumatism
Gout Isn't Always Easy to Prove: CT Scans Help Catch Cases Traditional Test Misses, Study Finds
Gout is on the rise among U.S. men and women, and this piercingly painful and most common form of inflammatory arthritis is turning out to be more complicated ...
Mayo Clinic
Inflammatory Arthritis and Sicca Syndrome Induced by Nivolumab and Ipilimumab
This EJournal Club series will exam, discuss, and assess of the most recent peer-reviewed literature on rheumatic diseases. Dr. Leonard Calabrese will lead an ...
ClevelandClinicCME
James R. Seibold, MD - Progress and Promise in Scleroderma Clinical Research
The first in our series of live webinars Dr. James Seibold, Principal Member of Scleroderma Research Consultants, LLC presented "Progress and Promise in ...
SRFCURE
Therapy of RA with Non-Biologic DMARDs -- ep. 21 of 32
Dr. Allan Gibofsky (Hospital for Special Surgery/ Weill Medical College of Cornell University) reviews data presented at the 2011 ACR Annual Meeting on the ...
ClevelandClinicCME
Sirukumab, a human anti-interleukin-6 monoclonal antibody
This EJournal Club series will engage rheumatologists, and other interested clinicians in an examination, discussion, and assessment of the most recent ...
ClevelandClinicCME
Biosimilars and Biologics
The webcast reviews biosimilars that treat rheumatologic diseases. Visit http://www.ccfcme.org/biovcmevideos to claim CME credit or learn more about the ...
ClevelandClinicCME
EULAR 2019 - Focus On WORD Day
EULAR 2019 - Focus On WORD Day (WOrld young Rheumatic Diseases Day: 18th March) at the annual European congress of rheumatology, EULAR 2019.
EULAR - European League against Rheumatism
9/13/2019 Lupus Disease, Disparities and New Directions: Strategies from HIV and Beyond
Christie Bartels, MD, MS, presents a talk about health disparities in the diagnosis and treatment of lupus, and how a care continuum model adapted from HIV ...
UW Department of Medicine
EULAR 2019 - Press conference: Pain symptoms and function in hand osteoarthritis
Low-dose prednisolone significantly improves pain symptoms and function in hand osteoarthritis. The results of the low-dose prednisolone in patients with hand ...
EULAR - European League against Rheumatism
Bernard-Soulier Syndrome (BSS)
Bernard-Soulier Syndrome (BSS) is an autosomal recessive (AR) disorder characterized by a defective GP1b platelet receptor leading to a problematic platelet ...
Medicosis Perfectionalis
Predicting Outcomes in RA - The Role of Biomarkers
This webcast will review several types of biomarkers, their classification criteria, the use of calprotectin, as well as MBDA scores in RA patients.
ClevelandClinicCME
Dosage interféron et Lupus Présentation de la publication ARD 2019
Interview FAI²R Actualités Maladies Rares Dosage interféron et Lupus Présentation de la publication ARD 2019 Par le Docteur Alexis MATHIAN Référence de ...
Filière de Santé FAI2R
RheumNow Podcast - COVID Kids and Men (5.15.20)
Dr. Jack Cush reviews the news and journal articles from the past week on RheumNow.com.
RheumNow
Treatment of Plaque Psoriasis Taking Big Steps Forward
The armament of medications and treatments for plaque psoriasis and psoriatic arthritis continues to grow giving doctors and patients more choices for their ...
HCPLive
Case: Challenges in Clinical Immunology
This clinical immunology video discusses challenges in clinical immunology, including autoimmune, autoinflammatory and immunodeficiency diseases.
ClevelandClinicCME
TNR Grand Rounds - Update on Biosimilars
Tuesday Nite Rheumatology features Dr Jonathan Kay (U Mass) - he gives an update on Biosimilars and took questions the subject. The program was ...
RheumNow
Why Personal Behavior Affects Immune Mediated Inflammatory Diseases (IMIDs) –– Leonard Calabrese, DO
In this free lecture, board-certified rheumatologist Leonard Calabrese, DO, Vice Chairman of the Cleveland Clinic's Department of Rheumatic and Immunological ...
The Institute for Functional Medicine
Genetic architecture distinguishes systemic juvenile idiopathic arthritis from other forms of juveni
Annals of the Rheumatic Diseases
TNR - COVID-Rheumatology Registry & COVID in OZ
Dr. Philip Robinson presents latest data on the Rheum-Covid.org Registry established by the Global Rheumatology Alliance. Dr. Peter Nash presents the impact ...
RheumNow
Outcome Tool Utilization Lecture
Allied Health lecture from the Cleveland Clinic Center for Continuing Education.
ClevelandClinicCME
The RheumNow Week in Review – Good News for GPA, CZP, Tofa but not ERA (6.1.18)
Dr. Jack Cush reviews this past weeks reports from RheumNow.com.
RheumNow
PASDAS Measures Disease Activity - Psoriatic Arthritis Posters and Abstracts from San Diego
Visit http://annenberg.net/Psoriatic-Arthritis-CE to access the activity, download resources and earn CE/CME credits. This video discusses: [1826] Secukinumab ...
Annenberg Center for Health Sciences
What Clinical Trials Do Not Teach Us: How to Achieve Remission in Rheumatoid Arthritis
A Department of Medicine Grand Rounds presented by Josef S. Smolen, MD, Medical University of Vienna.
Icahn School of Medicine
